Literature DB >> 8388371

Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH).

C Dahlöf1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8388371     DOI： 10.1111/j.1526-4610.1993.hed33040201.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  6 in total

Review 1.  Effective management of ice pick pains, SUNCT, and episodic and chronic paroxysmal hemicrania.

Authors:  L C Newman
Journal:  Curr Pain Headache Rep       Date:  2001-06

Review 2.  Paroxysmal hemicrania: an update.

Authors:  Sanjay Prakash; Rushad Patell
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 3.  [What is needed to develop a headache? Anatomical and pathophysiological implications].

Authors:  U Reuter; A May
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

Review 4.  Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 5.  Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

Authors:  Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni; Maria Michela Cainazzo; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2017-07-20       Impact factor: 7.277

Review 6.  Paroxysmal Hemicrania.

Authors:  Chinar Osman; Anish Bahra
Journal:  Ann Indian Acad Neurol       Date:  2018-04       Impact factor: 1.383
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.